Muscle relaxation controlled by automated administration of cisatracurium
Journal
Biomedical Engineering - Applications, Basis and Communications
Journal Volume
18
Journal Issue
6
Date Issued
2006-12-25
Author(s)
Abstract
In this paper, the muscle relaxant agent (i.e., cisatracurium) and three clinical control methods (i.e., 13 patients undergoing intermitted bolus control, 15 patients undergoing intensive manual control and 15 patients) undergoing automatic fuzzy logic control (FLC), were used for maintaining depth of muscle relaxation (DOM) during surgery. Cisatracurium, a muscle relaxation drug with long-term effect, low metabolic loading, but long delay time, is widely used in operating rooms and ICUs. Meanwhile, the rules for the FLC were developed from the experimental experience of intensive manual control after learning from 15 patient trials. According to experts' experimental experience, our FLC inputs were chosen from T1% error and trend T1% which differ from other previous studies on eliminating the effect of time delay from cisatracurium. In individual clinical experimental results, the mean(SD) of the mean T1% error in 13 patients for intermitted bolus control, in 15 patients for intensive manual control, and in 15 patients for automatic control was 8.76(1.46), 1.65(1.67), and 0.48(1.43), respectively. The t test results show that automatic control is not significantly different from intensive manual control. The results show that a simple fuzzy logic controller derived from anesthetists ' clinical trials can provide good accuracy without being affected by the pharmacological time delay problem.
Subjects
Automatic fuzzy logic control (FLC) | Cisatracurium | Delay time | Depth of muscle relaxation (DOM) | Intensive manual control | Intermitted bolus control
Type
journal article